Etoricoxib
- Createtime: 2026-04-14
- Updatetime: 2026-04-15
Product Details
| useage |
Industrial use
|
| deliveryInfo |
|
| appearance |
powder
|
| Molecular Weight |
358.84
|
| aliasen |
|
| supplyCapacity |
50000MT/Month
|
| harbor |
Qingdao,China
|
| minorder |
1KG
|
| Appearance |
White to pale yellow powder
|
Shandong Huashang Chemical Co., Ltd. is a high-tech enterprise specializing in the research and development, manufacturing, and sales of fine chemicals. Headquartered in Jinan, Shandong, China, we are committed to delivering high-quality products to our global partners. Currently, over 90% of our products are exported to developed markets, including North America, Europe, Japan, South Korea, and the Middle East.
CAS:202409-33-4
Molecular Formula:C??H??ClN?O?S
Molecular Weight:358.84
Alias:MK-0663; Arcoxia; Nucoxia;
Category:Selective COX-2 inhibitor, non-steroidal anti-inflammatory drug (NSAID)
Physical Properties
- Appearance:White to pale yellow crystalline powder
- Solubility:Practically insoluble in water (3.28e-03 g/L); soluble in DMSO
- Melting Point:134–135℃
- Boiling Point:510±50℃ (760 mmHg)
- Density:1.298±0.06 g/cm3
- LogP:5.26; PSA:68.3 ?2
- Storage:Inert atmosphere, 2–8℃, protected from light
Specification Sheet
| Item | Standard | Unit | Test Method |
| Appearance | White to pale yellow powder | – | Visual |
| CAS No | 202409-33-4 | – | Confirmation |
| Purity | ≥98.0 | % | HPLC |
| Water Content | ≤0.5 | % | KF |
| Melting Point | 134–135 | ℃ | Capillary |
| Residue on Ignition | ≤0.1 | % | Gravimetric |
Main Application
Selective COX-2 inhibitor with anti-inflammatory, analgesic, and antipyretic effects. Indicated for:
- Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis
- Acute gouty arthritis (120 mg once daily, max 8 days)
- Postoperative pain and primary dysmenorrhea
Mechanism: Selectively inhibits COX-2 (IC50=1.1 μM) over COX-1 (IC50=116 μM), reducing GI side effects while suppressing inflammation and pain.